Advisor Group’s Apollo Endosurgery, Inc. APEN Stock Holding History

Advisor Group’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-5	Closed	–	–	5296
2018 Q3	$0	Hold	5	–	–	﹤0.01%	5274
2018 Q2	$0	Hold	5	–	–	﹤0.01%	5091
2018 Q1	$0	Buy	+5	New	+$31	﹤0.01%	5112

Other funds holding APEN

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Advisor Group's APEN Position: Q4 2018 in Review

Advisor Group sold out of Apollo Endosurgery, Inc. (APEN) in Q4 2018, closing a stake of 5 shares.

Advisor Group first reported a position in APEN in Q1 2018 and held it in 3 quarters. The position peaked at $0 in Q3 2018. 35 funds tracked by Wall St. Rank hold APEN as of Q4 2018.

Advisor Group reported no remaining Apollo Endosurgery, Inc. position as of Q4 2018 after selling out during the quarter.
Advisor Group sold 5 Apollo Endosurgery, Inc. shares in Q4 2018.
Advisor Group first reported a position in Apollo Endosurgery, Inc. in Q1 2018 and held it in 3 quarters.
Advisor Group's Apollo Endosurgery, Inc. position peaked at $0 in Q3 2018.
35 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q4 2018.

Based on Advisor Group's 13F filing for Q4 2018, filed 11 Feb 2019.